Table:
begin	end	state
1	25	signal peptide
26	33	non-cytoplasmic
34	55	transmembrane
56	61	cytoplasmic
62	80	transmembrane
81	85	non-cytoplasmic
86	107	transmembrane
108	113	cytoplasmic
114	132	transmembrane
133	161	non-cytoplasmic
162	181	transmembrane
182	206	cytoplasmic
207	228	transmembrane
229	247	non-cytoplasmic
248	273	transmembrane
274	288	cytoplasmic
289	307	transmembrane
308	594	non-cytoplasmic

Input:
>BPHYT_RS19450 FitnessBrowser__BFirm:BPHYT_RS19450
MKRIMQNKFFWLFLVVLFALPVLPQPIHVPEYWVTLLNYIGLYSIVAIGLVLLTGIGGMT
SFGQAAFVGIGAYATAYLTTRYGVSPWLALIAGVAVTALIALMLGLVTMRLSGHFLPLGT
IAWGLALFYLFGNLEMLGKYDGINGIPVLNVFGIDLESGRHIYYLIWLVVLGAVISVQNL
LNSRPGRAIRALRGGGMMAEAMGVNTGWMRVVIFVYAAVLAAVSGFLYAHLQRAVNPTPF
GLNHGIEFLFMAVVGGVSHVWGAVLGAAILTVLQDYLQTLLPKLLGENGNFEVIVFGILM
VLLLQYARQGVWPFVARFFPKGPRAHLADHAEPLPQRSKPAAGEDLLTVNKARKQFGGLV
AVNDVSFEVKAGQIIGLIGPNGAGKSTTFNLVTGVLQATSGEITFCGERIDSLSSREIVK
RGIGRTFQHVKLLPGMTVLENVAIGAHLRGQAGVWRSVVRLNSAEEARLMAEAARQIRRV
GLEQHMYDEAGSLALGQQRILEIARALCCDPTLLLLDEPAAGLRYQEKLQLADLLRRLKA
EGMSVLLVEHDMDFVMNLTDRLVVMEFGTRIAEGLPQEVQQDPAVLEAYLGGVE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server